DW's individualized German language learning materials can help you to improve your skills with a host of fun and free materials for all levels. dw.com/germancourses We welcome posts in English and German. However, DW will delete and/or report any content that constitutes hateful, threatening, pornographic or harrassing material. Please respect our netiquette: http://bit.ly/b3Ui11 Legal Notice: http://www.dw.com/dw/article/0,,15718489,00.html
Manage episode 302636725 series 1836531
بواسطة LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science، اكتشفه Player FM ومجتمعنا ـ حقوق الطبع والنشر مملوكة للناشر وليس لـPlayer FM، والصوت يبث مباشرة من خوادمه. اضغط زر الاشتراك لمتابعة التحديثات في Player FM، أو ألصق رابط التغذية الراجعة في أي تطبيق بودكاست آخر.
COVID-19 has upended our lives in how we interact and function. As of September 2021, the Centers for Disease Control estimate over 40 million people have been sick and approximately 652,000 people have died in the United States. We see that vaccines and mask-wearing are effective in controlling the spread, but people are still getting sick. We can’t fully eradicate COVID, but what if we could more effectively treat the symptoms of those infected and shorten the duration of their illness? LSU alumna, Darnisha Harrison, the Founder, President & CEO of Ennaid Therapeutics is working to answer that question. In this episode, Darnisha shares the inception of her company and the driving, divine mission to tackle diseases and identify treatments suitable for all of society. Catch more of Darnisha Harrison's story on a previous post on Science Next, "Will it take more than a vaccine to beat the Coronavirus?" Learn about Ennaid Therapeutics: https://ennaidthera.com/